While the imperatives for conducting DCTs have waned, now is not the time to revert to requiring onsite visits for everything, expert says.
The time is ripe for clinical researchers to teach the public what efforts to increase its involvement in trials are really all about.
Don’t sell your site short when competing against the big kids on the block for new trials, expert says.
Change is hurtling toward clinical trial practitioners like a runaway train, and now is the time to get ready for it.
“Agile clinical trials are about taking the clinical trial to wherever the patient is.”